® Consulta de Marcas Base do INPI · pesquisa e monitoramento

(marca figurativa)

Registro de marca em vigor (Madri)

Marca Figurativa depositada no INPI em 21/03/2023 por MILEUTIS LTD, processo nº 501724571, nas classes 05. Registro em vigor até 21/03/2033.

Número do processo501724571
SituaçãoRegistro de marca em vigor (Madri)
ApresentaçãoFigurativa
NaturezaMadri Produto/Serviço
Data do depósito21/03/2023
Data da concessão19/11/2024
Vigência até21/03/2033
TitularMILEUTIS LTD
CNPJ/CPF do titular
UF · País— · IL

Classes e especificação

Classe 05 — Farmacêuticos e saúde

Intramammary and intrauterine veterinary preparations; intramammary and intrauterine pharmaceutical and medical preparations for human use; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of mastitis, breast inflammation, mammary infections, and mammary disorders; pharmaceutical preparations, veterinary preparations, and medical preparations for the treatment and prevention of metritis; pharmaceutical preparations, veterinary preparations, and medical preparations for the prevention and treatment of uterine infections; veterinary preparations for increasing milk production and improving feed efficiency; animal feed additive for use as a nutritional supplement for medical purposes; pharmaceutical and medical preparations for increasing milk production; veterinary preparations for the prevention and treatment of bacterial infections, disorders, conditions, and diseases; pharmaceutical preparations and medical preparations for the prevention and treatment of bacterial infections, disorders, conditions, and diseases; pharmaceutical preparations, veterinary preparations and medical preparations for the involution of the udder or the mammary gland; pharmaceutical preparations, veterinary preparations and medical preparations for reduction of somatic cell count; veterinary preparations, and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms related to infections in lactating animals during the lactation period; veterinary and pharmaceutical preparations for increasing the welfare and comfort of lactating animals, namely, to reduce, eliminate and treat symptoms involved with the dry-off period in lactating animals; pharmaceutical and medical preparations for the prevention and treatment of lactation-related medical conditions; pharmaceutical preparations, veterinary preparations and medical preparations for the treatment and prevention of infections, diseases, disorders and conditions in poultry, and for promoting growth or the welfare of poultry; pharmaceutical and medical preparations for the prevention or treatment of buccal diseases, disorders and conditions; pharmaceutical and medical preparations for the prevention or treatment of central, peripherical and neuronal nervous system conditions; pharmaceutical and medical preparations for the prevention or treatment of gastro-intestinal diseases, disorders and conditions; pharmaceutical and medical preparations for the prevention or treatment of diseases, disorders and conditions of the skeletal system and the bones; medical and veterinary preparations to regulate and adapt the mammalian gut microbiome for disease prevention and wellness; pharmaceutical preparations, medical preparations, and veterinary preparations for the treatment of wounds, or damages to the skin and tissues; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of dermatological disorders, or skin diseases, disorders and conditions related to hyperactive immune response, or allergic reactions and conditions; pharmaceutical preparations, medical preparations, and veterinary preparations for the prevention and treatment of medical conditions and diseases associated with immunostimulation or immunomodulation; synthetic and biological peptides for the treatment of conditions and diseases associated with immunostimulation, or for immunomodulation; pharmaceutical, medical and veterinary preparations.;

Acompanhe este processo

Receba um e-mail a cada novo despacho publicado na RPI para o processo 501724571 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.

Monitorar esta marca Ver marcas parecidas

Andamento do processo no INPI

3 despacho(s) publicado(s) na Revista da Propriedade Industrial.

  1. 19/11/2024 Concessão de registro em designação código IPAS770 · RPI 2811
  2. 20/08/2024 Deferimento de designação código IPAS768 · RPI 2798
  3. 29/08/2023 Publicação de pedido de registro para oposição (exame formal de designação concluído) código IPAS756 · RPI 2747

Outras marcas de MILEUTIS LTD

Classificação figurativa (Viena)